MDxHealth S.A.
MDXH
Rangering i aksjer
#21612
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Aksjekurs
$3.39
Sist synkronisert: 2023-12-15
Markedsverdi
$96.16M
Endring (1 dag)
-1.73%
Endring (1 år)
0.01%
Land
BE
Handel MDxHealth S.A. (MDXH)
Kategori
Healthcare
Aksjeprishistorikk for MDxHealth S.A. (MDXH)
Høyeste sluttskurs: $3.30 den 2023-12-01
Laveste sluttskurs: $109.85 den 2008-08-01
Laveste sluttskurs: $109.85 den 2008-08-01
Aksjeprishistorikk for MDxHealth S.A. fra 2008 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2023 | -52.10% |
| 2022 | -33.51% |
| 2021 | 0.16% |
| 2020 | -8.63% |
| 2019 | -47.39% |
| 2018 | -49.31% |
| 2017 | -10.95% |
| 2016 | 3.69% |
| 2015 | -5.94% |
| 2014 | 20.96% |
| 2013 | 75.72% |
| 2012 | 7.83% |
| 2011 | -80.58% |
| 2008 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $676.48 | 19.27% |
US
|
|
| $229.93 | 5.42% |
US
|
|
| $398.85 | 112.13% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $174.35 | 19.52% |
US
|
